Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Oncogene
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
12 December 2002, Volume 21, Number 57, Pages 8705-8712
Table of contents    Previous  Abstract  Next   Full text  PDF
Original Paper
Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells
Santhi D Konduri1, Niranjan Yanamandra1, Khawar Siddique2, Arun Joseph1, Dzung H Dinh2, William C Olivero2, Meena Gujrati3, Gregory Kouraklis4, Amand Swaroop5, Athanassios P Kyritsis6 and Jasti S Rao1,2

1Division of Cancer Biology, Department of Biomedical and Therapeutic Sciences, University of Illinois, Peoria, Illinois, USA

2Department of Neurosurgery, University of Illinois, Peoria, Illinois, USA

3Department of Neuro-pathology, University of Illinois, Peoria, Illinois, USA

4Department of Propedeutic Surgery, Athens University School of Medicine, Athens, Greece

5Department of Ophthalmology & Visual Sciences and Human Genetics, WK Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA

6Department of Neurology, University of Ioannina School of Medicine, Ioannina, Greece

Correspondence to: J S Rao, Division of Cancer Biology, Department of Biomedical and Therapeutic Sciences and Department of Neurosurgery, Box 1649, University of Illinois, College of Medicine at Peoria, Peoria, IL 61656, USA; E-mail: jsrao@uic.edu

Abstract

Increases in the abundance of cathepsin B transcript and protein with increased tumor grade and changes in subcellular localization and activity of this enzyme. We observed progressive reductions in levels of the protease inhibitor cystatin C, an inhibitor of cathepsin B with corresponding increases in the malignancy of glioma cell lines, implying an inverse correlation between cystatin C and tumor grade. To investigate the role of cystatin C in the invasion of brain tumor cells, we stably transfected SNB19 glioblastoma cells with either a 0.4-kb cDNA construct of human cystatin C in the sense orientation or an empty vector. Clones expressing sense-cystatin C cDNA had higher cystatin C mRNA and protein levels than did control cells. Sense-transfected cells were also markedly less invasive than control cells in a Matrigel invasion assay and in a coculture assay of SNB19 spheroids and fetal rat brain aggregates. Finally, the sense-transfected cells did not form tumors in nude mice upon intracerebral injection. These results strongly implicate cystatin C in the invasiveness of human glioblastoma cells and suggest that sense transcripts of cystatin C may prove useful in cancer therapy.

Oncogene (2002) 21, 8705-8712. doi:10.1038/sj.onc.1205949

Keywords

glioma; invasion; cathepsin B; cystatin C

Received 9 April 2002; revised 31 July 2002; accepted 7 August 2002
12 December 2002, Volume 21, Number 57, Pages 8705-8712
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group